Tidepool announced today that it secured a new certification for its open-source quality management system, known as qmsOS.

Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.

A review of several studies highlighted the role smart infusion pump interoperability can play in medication administration.

Satio and Nanowear today announced that they partnered to advance patient-friendly, home-based diagnostic and therapeutic ...

Aptar Digital Health today announced survey findings showcasing the impact of its iPump connected assistant for medication ...

Howard Look announced that he is stepping down from his role as CEO at automated insulin delivery technology developer Tidepool. Look, who co-founded the Palo Alto, California-based company in 2013, ...

Retractable Technologies (NYSE:RVP) announced today that it reduced its workforce by approximately 7%. The Little Elm, Texas-based maker of products like syringes and needles said the move comes as it ...

The 15-day G7 CGM in use. [Image courtesy of Dexcom] Dexcom (Nadsaq:DXCM) announced today that the FDA cleared its G7 15-day continuous glucose monitoring (CGM) system. The clearance covers people ...

Leading automated insulin delivery (AID) technologies for people with diabetes. [Images courtesy of Insulet, Tandem Diabetes Care, Sequel Med Tech, Medtronic and Beta Bionics] Key opinion leaders ...

[Image from the Vaxess website] Shelf-stable vaccine patch maker Vaxess Technologies announced today that it received an additional $9 million in funding. Participants in the latest funding round for ...

Needham analysts report that ICU Medical (Nasdaq: ICUI) has a plan in place to handle its exposure to the tariffs imposed by the Trump Administration. Medtech stocks already took a hit last month as ...